SCHEMBL7612883

SCHEMBL7612883

O=C(O)C=Cc1ccc2cc[nH]c2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.65
CYP2A6 P11509 1/20 0.59
APP P05067 5/20 0.55
MAPT P10636 5/20 0.55
CCNC P24863 2/20 0.53
CDK8 P49336 2/20 0.53
KDM4E B2RXH2 5/20 0.53
HSD17B10 Q99714 4/20 0.53
ALDH1A1 P00352 3/20 0.53
HPGD P15428 3/20 0.53
ENPP2 Q13822 1/20 0.53
HDAC2 Q92769 3/20 0.50
CA12 O43570 2/20 0.50
AKR1B10 O60218 2/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA3 P07451 2/20 0.50
AKR1B1 P15121 2/20 0.50
CA4 P22748 2/20 0.50
CA6 P23280 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7612873 1.00 BACE1 (0.65) BACE1CYP2A6APPMAPTCCNC
SCHEMBL3446464 0.87 CYP2A6 (0.59) BACE1CYP2A6APPMAPTCCNC
SCHEMBL31419517 0.87 CYP2A6 (0.59) BACE1CYP2A6APPMAPTCCNC
SCHEMBL3446463 0.87 CYP2A6 (0.59) BACE1CYP2A6APPMAPTCCNC
SCHEMBL3221778 0.85 BACE1 (0.86) BACE1CYP2A6APPMAPTKDM4E
SCHEMBL3221793 0.85 BACE1 (0.86) BACE1CYP2A6APPMAPTKDM4E
SCHEMBL7621979 0.85 BACE1 (0.63) BACE1CYP2A6APPMAPTKDM4E
SCHEMBL4147823 0.83 BACE1 (0.78) BACE1CYP2A6APPMAPTCCNC
SCHEMBL4147831 0.83 BACE1 (0.78) BACE1CYP2A6APPMAPTCCNC
SCHEMBL2508821 0.81 APP (0.64) BACE1CYP2A6APPMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0165613-A2 Process for controlling culture of recombinants HITACHI, LTD. (JP) 1985-12-27 EP claimed
US-6465485-B1 SUCH AS 7-CYANO-2-(2-(1-(4-(2-INDOLYL)CARBOXAMIDO)CYCLO-HEXYL)ETHYL)-1,2,3,4 -TETRAHYDROISOQUINOLINE; ANTIPSYCHOTIC AGENTS SMITHKLINE BEECHAM P.L.C. (GB) 2002-10-15 US disclosed
EP-1100495-A4 PROPENAMIDES AS CCR5 MODULATORS SMITHKLINE BEECHAM CORP (US) 2002-09-25 EP disclosed
EP-1100495-A1 PROPENAMIDES AS CCR5 MODULATORS SMITHKLINE BEECHAM CORPORATION (US) 2001-05-23 EP disclosed
WO-2000006153-A1 PROPENAMIDES AS CCR5 MODULATORS SMITHKLINE BEECHAM CORPORATION (US) 2000-02-10 WO disclosed
EP-0901470-A1 INDOLE DERIVATIVES USEFUL AS ENDOTHELIN RECEPTOR ANTAGONISTS PFIZER INC. (US) 1999-03-17 EP disclosed
WO-1997043260-A1 INDOLE DERIVATIVES USEFUL AS ENDOTHELIN RECEPTOR ANTAGONISTS PFIZER INC. (US) 1997-11-20 WO disclosed
EP-0290145-B1 Aliphatic carboxamides ICI AMERICA INC (US) 1994-10-26 EP disclosed
US-4894386-A ANTIINFLAMMATORY AGENTS ICI AMERICAS INC. (US) 1990-01-16 US disclosed
EP-0290145-A1 Aliphatic carboxamides ZENECA INC. (US) 1988-11-09 EP disclosed
EP-0200417-A2 Production of protein Takeda Chemical Industries, Ltd. (JP) 1986-11-05 EP disclosed
EP-0176916-A2 Process for production of gamma-interferon FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-04-09 EP disclosed